Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Prof. Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Prof. Chyi-Liang Chen, Linkou Chang Gung Memorial Hospital Children’s Medical Center, Taiwan

๐Ÿงฌ Prof. Chyi-Liang Chen is an Associate Researcher at Chang Gung Memorial Hospital and the Department of Microbiology and Immunology, Chang Gung University, Taiwan. He earned his BSc, MSc, and PhD in Life Sciences from National Chung Hsing University. With extensive postdoctoral research at Chang Gung University and the University of Calgary, his expertise spans microbiology, molecular microbiology, protein engineering, bacterial genomics, and antimicrobial resistance. He has authored numerous SCIE-indexed publications on bacterial pathogenesis and genetic engineering. His work contributes to biotechnology, genomics, and patent applications, advancing microbial research. ๐Ÿฆ ๐Ÿ”ฌ๐Ÿ“š

Publication Profile

Scopus

Orcid

๐ŸŽ“ Educational Background

Prof. Chyi-Liang Chen pursued his academic journey in Life Sciences at National Chung Hsing University, Taiwan. He obtained his Bachelorโ€™s degree (1984โ€“1988) from the Department of Life Sciences (formerly the Department of Botany). He then completed his Masterโ€™s degree (1988โ€“1990) at the Institute of Life Sciences (previously the Institute of Botany Microbiome). Further advancing his expertise, he earned a Ph.D. (1990โ€“1995) from the same institute. His strong foundation in microbiology, molecular biology, and botany has significantly contributed to his impactful research in bacterial genomics and biotechnology. ๐Ÿงฌ๐Ÿ”ฌ๐Ÿ“–

๐Ÿ… Professional Experience

Prof. Chyi-Liang Chen has an extensive career in microbiology and immunology. He began as a Postdoctoral Fellow at Chang Gung University, Taiwan (1997โ€“1999) before moving to the University of Calgary, Canada (1999โ€“2002). He later returned to Chang Gung University (2002โ€“2006). He served as an Assistant Professor at Yuanzhi University and later as an Assistant Researcher at Chang Gung Memorial Hospital (2006โ€“2012). Since 2012, he has been an Associate Researcher at Chang Gung Memorial Hospital and, from 2022, also at the Department of Microbiology and Immunology, Chang Gung University. ๐Ÿงช๐Ÿ”ฌ๐Ÿ“š

๐Ÿ”ฌ Research Focus

Prof. Chyi-Liang Chen specializes in infectious diseases, microbiology, and immunology. His research spans viral infections ๐Ÿฆ , antimicrobial resistance ๐Ÿ’Š, and host-pathogen interactions ๐Ÿฅ. He has contributed to studies on multiple viral infections in children, cytomegalovirus colitis, and antiviral treatments. His work also explores the gut microbiota’s role in cancer therapy and cross-species microRNAs. Additionally, he has investigated COVID-19 therapeutics ๐Ÿ˜ท and SARS-CoV-2 variants ๐Ÿงฌ. His studies provide crucial insights into infectious disease management, making significant contributions to global health and microbiological research. ๐ŸŒ๐Ÿ”

Publication Top Notes

1๏ธโƒฃ Multiple viral infections and antimicrobial use in hospitalized children with respiratory illness during pandemic and early post-pandemic era, Taiwan ๐Ÿฆ ๐Ÿ’Š (Heliyon, 2025)ย 
2๏ธโƒฃ Identifying the function of novel cross-species microRNAs from the excretory-secretory products of Angiostrongylus cantonensis fifth-stage larvae ๐Ÿงฌ๐Ÿฆ  (Journal of Microbiology, Immunology and Infection, 2025)ย 
3๏ธโƒฃ Maternal Infections, Antibiotics, Steroid Use, and Diabetes Mellitus Increase Risk of Early-Onset Sepsis in Preterm Neonates ๐Ÿคฐ๐Ÿฆ  (Pathogens, 2025)ย 
4๏ธโƒฃ Adequate antiviral treatment lowers overall complications of cytomegalovirus colitis among inpatients with inflammatory bowel diseases ๐Ÿ’Š๐Ÿฆ  (BMC Infectious Diseases, 2024) – 2 citations
5๏ธโƒฃ Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer ๐Ÿฆ ๐Ÿงช (Biomedical Journal, 2024) – 5 citations
6๏ธโƒฃ Antimicrobial activity of eravacycline and other comparative agents on aerobic and anaerobic bacterial pathogens in Taiwan ๐Ÿ’Š๐Ÿฆ  (Journal of Global Antimicrobial Resistance, 2024) – 1 citation
7๏ธโƒฃ Complete genome sequence of Bacillus halotolerans F29-3, a fengycin-producing strain ๐Ÿงฌ๐Ÿฆ  (Microbiology Resource Announcements, 2024)ย 
8๏ธโƒฃ Cytomegalovirus Diseases of the Gastrointestinal Tract in Immunocompetent Patients: A Narrative Review ๐Ÿฆ ๐Ÿ“– (Viruses, 2024) – 5 citations
9๏ธโƒฃ Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(ฮฑK) in mild-to-moderate COVID-19 patients ๐Ÿ’‰๐Ÿฆ  (Human Vaccines and Immunotherapeutics, 2024)ย 
๐Ÿ”Ÿ Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives ๐Ÿฆ ๐Ÿ’‰ (Journal of the Formosan Medical Association, 2024) – 1 citation

Conclusion

Prof. Chyi-Liang Chen is highly suitable for the Best Researcher Award due to his strong academic background, international research experience, expertise in microbiology and bacterial pathogenesis, and high-impact publications. His work has significantly advanced molecular microbiology and biotechnology, making him a worthy candidate for this prestigious recognition.

Qibing Zeng | Environmental Health | Best Researcher Award

Prof. Dr. Qibing Zeng | Environmental Health | Best Researcher Award

Professor at Chinese Center for Disease Control and Prevention , China

Prof. Dr. Qibing Zengย  is a Professor at the National Institute for Occupational Health and Poison Control, China CDC. He holds a Doctor of Medicine (2020) and a Master of Medicine (2011) in Toxicology from Guizhou Medical University. His research focuses on organoid-based disease models ๐Ÿงฌ, environmental and genetic epidemiology ๐ŸŒ, and bioactive natural products in metabolic disease treatment. Dr. Zeng has led multiple national research projects on arsenic poisoning, metabolic diseases, and environmental toxicology. Previously, he served as a Professor at Guizhou Medical University. His work contributes to understanding disease mechanisms and advancing translational medicine. ๐Ÿ“ฉ

Publication Profileย 

Google Scholar

๐ŸŽ“ Academic Qualifications

Prof. Dr. Qibing Zengย  holds a Doctor of Medicine (2020) in Toxicology from Guizhou Medical University, where he specialized in environmental toxicology and disease mechanisms. He earned his Master of Medicine (2011) in Hygiene of Toxicology from the same institution, formerly known as Guiyang Medical College, focusing on public health and toxicological safety . His academic journey began with a Bachelor of Medicine (2008) in Clinical Medicine (Oncology), where he gained foundational expertise in cancer research and treatment . Dr. Zeng’s strong educational background supports his extensive research in toxicology, metabolic diseases, and environmental health. ๐Ÿ“š๐Ÿ”ฌ

๐Ÿ‘จโ€๐Ÿซ Work Experience

Prof. Dr. Qibing Zeng ย is a Professor at the National Institute for Occupational Health and Poison Control, China CDC (2024โ€“present), focusing on toxicology and disease prevention . Previously, he served as a Professor at the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Guizhou Medical University (2022โ€“2024) . He was an Associate Professor (2017โ€“2021) and Lecturer (2014โ€“2016) at the School of Public Health, Guizhou Medical University, where he contributed to environmental health research . His academic career began as a Teaching Assistant (2011โ€“2013), laying the foundation for his expertise in toxicology and public health. ๐Ÿ“š๐Ÿ”ฌ

Research Focusย 

Prof. Dr. Qibing Zengโ€™s research primarily focuses on toxicology, metabolic diseases, and organoid-based disease models. His work explores environmental and genetic epidemiology ๐Ÿงฌ, investigating how pollutants like arsenic and fluorine affect human health . He also studies the mechanisms of bioactive natural products ย in treating metabolic disorders. His projects include 3D skin organoid models , arsenic-induced toxicity, and disease progression in endemic regions . Through these studies, he aims to develop translational applications for public health and occupational safety, contributing to disease prevention and toxicological interventions ๐Ÿ”ฌ

Publication Top Notes

๐Ÿ”น The risk factors for diabetic peripheral neuropathy: a meta-analysis
๐Ÿ“… Year: 2019 | ๐Ÿ” Cited by: 247

๐Ÿ”น Global trends and forecasts of breast cancer incidence and deaths
๐Ÿ“… Year: 2023 | ๐Ÿ” Cited by: 161

๐Ÿ”น Assessing potential mechanisms of arsenic-induced skin lesions and cancers: Human and in vitro evidence
๐Ÿ“… Year: 2020 | ๐Ÿ” Cited by: 71

๐Ÿ”น Association and risk of five miRNAs with arsenic-induced multiorgan damage
๐Ÿ“… Year: 2019 | ๐Ÿ” Cited by: 65

๐Ÿ”น Alterations of arsenic levels in arsenicosis residents and awareness of its risk factors: a population-based 20-year follow-up study in a unique coal-borne arsenicosis county
๐Ÿ“… Year: 2019 |

Conclusion

Dr. Qibing Zeng is a distinguished researcher in toxicology, epidemiology, and metabolic diseases, holding a Doctor of Medicine and multiple advanced degrees. As a professor at China CDC, he has led nationally funded projects and contributed significantly to environmental health and disease prevention. His research, published in high-impact journals like Bioactive Materials and Science of the Total Environment, has gained substantial citations, reflecting its in scientific impact. With expertise spanning public health, molecular toxicology, and epidemiology, Dr. Zengโ€™s leadership and multidisciplinary collaborations position him as a strong contender for the Best Researcher Award. ๐Ÿ†๐Ÿ”ฌ๐Ÿš€.